Kronos Bio
Acquired
Pioneering precision oncology
- Headquarters
- San Mateo, California
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- kronosbio.com
- Total Funding
- $260.0M
- Last Round
- $155.0M Series BAug 2020
About
Kronos Bio is a clinical-stage biopharmaceutical company focused on developing small-molecule therapeutics that target deregulated transcription factors to treat cancer and other diseases.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account